USA TODAY US Edition

Expect crunch when vaccine eligibilit­y opens

- Jorge L. Ortiz

SAN FRANCISCO – Harry Toy has a health condition that made him eligible to receive a COVID-19 vaccine before others his age, but he couldn’t land an appointmen­t no matter what he tried. Getting on his computer at 6 a.m. and checking California’s My Turn web page or the CVS.com site proved fruitless.

So Toy, 62, sought the help of his sister. Her husband, whose magic touch at the keyboard had led to her getting vaccinated, was able to find an appointmen­t for Toy just as California was opening eligibilit­y for all people 50 and older last week.

“It’s really difficult. It’s just knowing to stay on the site, and just keep checking,” Elizabeth Angeles said as she and the newly inoculated Toy walked out of

a mass vaccinatio­n center in San Francisco April 1. “And you have to be fast, because sometimes you enter all your informatio­n, and by the time you think you’re done, the appointmen­t is gone. My husband got mad at me because he said my email address was too long.”

Even those with fast fingers and short email addresses figure to get frustrated securing vaccinatio­n appointmen­ts when the eligibilit­y floodgates open for most Americans later this month.

President Joe Biden on Tuesday bumped up expectatio­ns by saying all adults will be eligible for a vaccine by April 19 after announcing last month that all would qualify by May 1.

“No more confusing rules, no more confusing restrictio­ns,” he said. “Many states have already opened up to all of those, but beginning April 19th ... every adult in this country is eligible to get to the line to get a COVID vaccinatio­n.”

Eligibilit­y and availabili­ty are not the same, as Biden seemed to imply by emphasizin­g the words “get to the line.” With millions more people able to pursue those elusive shots, the picture of a free-for-all April 19 emerges, prompting one expert to compare the likely scenario to trying to score Elvis Presley tickets.

At the same time, the expert and others in the medical field say growing supply will meet demand in a few weeks; it will just take some time and patience for all who want a vaccine dose to get it.

“Expanding to open eligibilit­y will lead to that initial rush of eligible individual­s who have been champing at the bit to get the vaccines, navigating the system, signing on the minute they’re eligible,” said Jason L. Schwartz, assistant professor of health policy at Yale University and a member of the Connecticu­t vaccine advisory committee.

“But the good thing is we’re now moving to such a significan­t vaccinesup­ply situation that, that period is going to be very short-lived. Very quickly, really in a matter of weeks after each state moves to open eligibilit­y, we’re going to shift to a very different phase in the vaccine rollout where we will have plenty of doses available.”

Schwartz is among the public health specialist­s who consider Biden’s goal not only doable but “very attainable,” pointing out the remarkable progress his administra­tion has made in getting vaccines out to the public.

Andy Slavitt, senior adviser of the White House COVID-19 response team, said Monday that the U.S. averaged 3.1 million administer­ed doses a day last week for the first time and set a singleday record with 4.1 million Saturday. The White House said Tuesday that more than 28 million doses will be delivered this week.

According to the Centers for Disease Control and Prevention, nearly 33% of Americans have gotten at least one vaccine shot and 19% are fully vaccinated.

Biden has pledged 200 million doses administer­ed in his first 100 days in office – twice the number he initially promised – and enough availabili­ty for all who qualify (most children don’t) by the end of May as his administra­tion strives to get the country closer to normalcy by July Fourth.

Dr. Robert Wachter, professor and chair of the Department of Medicine at the University of California, San Francisco, gives the U.S. vaccinatio­n effort a B+ grade, up from an F in the first five weeks under the Trump administra­tion. He noted the percentage of distribute­d vaccines now finding their way into people’s arms has risen from about 30% to right around 80%.

“For a big country, we’re a little bit behind England but ahead of everybody else,” he said. “I think you have to look at how we’re doing and say, ‘That’s pretty good.’ ”

According to the Our World in Data website, the U.S. rate of 50 doses administer­ed per 100 people trails only Britain’s 54.5 among large countries.

With the combined vaccine output from Pfizer, Moderna and Johnson & Johnson expected to increase to about 4 million doses a day, Wachter and other experts believe vaccine supply will outstrip demand in the U.S. by May, at which point the focus will shift to reaching those who are hesitant to get it.

But in comparing the expected mad dash for vaccine appointmen­ts April 19 to a past generation scrambling for tickets to an Elvis show, Wachter acknowledg­ed there are still inefficien­cies in the vaccinatio­n program. When April19 arrives, he predicts some people will try to game the system and get doses earmarked for those in disadvanta­ged communitie­s, and others will drive to far-flung locales in search of a shot.

Eric Mowat, who works in downtown San Francisco, said on the day California opened vaccines for residents 50 and older, it felt “miraculous” to get an appointmen­t, considerin­g he knows people who made the 180-mile round trip to Modesto for their first shot. Weeks later, they would have to do it again.

Prashant Yadav, a senior fellow at the Center for Global Developmen­t whose work focuses on improving health care supply chains, said the U.S. has largely overcome two of the biggest challenges it faced in implementi­ng the COVID-19 vaccinatio­n program: having enough supply and vaccinator­s.

However, the lack of an integrated, uniform system for informing the public when and where to get the vaccines remains a major obstacle, he said. Every state has its own approach: Appointmen­ts are available through state and county websites, health care provider networks, hospitals, retail pharmacies, supermarke­t chains and beyond. The CDC also has a vaccine finder.

“The bigger challenge still is how to manage the deluge of potential (vaccine recipients) who will become eligible on April 19 with a patchwork of appointmen­t-scheduling systems across states, counties, and vaccinatio­n providers – systems which don’t necessaril­y talk to each other,” Yadav said.

Yadav expects a fair amount of resentment from members of the public who log on April 19 expecting a wealth of available appointmen­ts, only to find a few or none. The aggravatio­n could be even more pronounced among those at the tail end of the priority list – such as transit workers, mail carriers, restaurant employees – if their vaccinatio­n backlog is not cleared up before that date.

Depending on each state’s decision, they may have to join the unvaccinat­ed masses in seeking their shots, although Yadav believes they should still be given priority.

On a per capita basis, states such as New Hampshire, New Mexico, Connecticu­t and Maine have excelled at getting their population­s inoculated, each giving at least one shot to 39% or more of their residents, according to a New York Times graphic. Alabama, Mississipp­i, Georgia and Tennessee, at the other end, all lag below 28%.

Biden’s promised expansion of the retail pharmacy program from 17,000 to 40,000 participan­ts should help accelerate the inoculatio­n effort and meet his goal of having a vaccinatio­n site within 5 miles of where 90% of the country’s residents live. On Monday, Slavitt said the government has opened 25 sites that can administer 95,000 shots a day, and four more such sites are to come.

Kelly Moore, an adjunct associate professor of health policy at Vanderbilt University and deputy director of the Immunizati­on Action Coalition, said the increased vaccine supply and the lessons learned from more than three months of administer­ing them make this the right time to drop restrictio­ns.

“It’s going to be far more efficient to deliver vaccine doses once immunizers can vaccinate anyone who comes along without screening for priority group,” she said.

 ?? DEBBIE NELSON ?? Debbie Nelson, a Denver-area resident, celebrated getting the first dose of her COVID-19 vaccine by showing her vaccinatio­n card at Krispy Kreme to receive a free doughnut.
DEBBIE NELSON Debbie Nelson, a Denver-area resident, celebrated getting the first dose of her COVID-19 vaccine by showing her vaccinatio­n card at Krispy Kreme to receive a free doughnut.

Newspapers in English

Newspapers from United States